News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,175 Results
Type
Article (8093)
Company Profile (140)
Press Release (477941)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166854)
Career Advice (304)
Deals (25765)
Drug Delivery (7)
Drug Development (52969)
Employer Resources (14)
FDA (9785)
Job Trends (8587)
News (238412)
Policy (17922)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (491)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33178)
ALS (107)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (279)
Approvals (10423)
Artificial intelligence (328)
ASCO (159)
Autoimmune disease (218)
Automation (29)
Bankruptcy (264)
Belgium (1)
Best Places to Work (6972)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (115)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (523)
Cancer (3741)
Cardiovascular disease (225)
Career advice (245)
Career pathing (1)
CAR-T (177)
CDMO (12)
Celiac Disease (1)
Cell therapy (484)
Cervical cancer (35)
Clinical research (48082)
Collaboration (1274)
Commercialization (3)
Company closure (2)
Compensation (1523)
Complete response letters (34)
COVID-19 (763)
CRISPR (64)
C-suite (796)
Cystic fibrosis (86)
Data (5830)
Denatured (4)
Depression (103)
Dermatology (68)
Diabetes (351)
Diagnostics (4204)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73763)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88088)
Executive appointments (712)
FDA (12488)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (939)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (296)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9384)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (66)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (159)
Infectious disease (953)
Inflammatory bowel disease (128)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (41)
IPO (12397)
IRA (2)
Job creations (1969)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (17)
Liver cancer (45)
Longevity (19)
Lung cancer (529)
Lymphoma (258)
Machine learning (27)
Management (3)
Manufacturing (557)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8683)
Medtech (8838)
Mergers & acquisitions (14427)
Metabolic disorders (723)
mRNA (60)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (41)
Neuroscience (1856)
NextGen: Class of 2026 (3158)
Non-profit (850)
Obesity (230)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (205)
Parkinson's disease (204)
Partnered (12)
Patents (491)
Patient recruitment (527)
Patient selection (1)
Peanut (31)
People (41366)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15537)
Phase 2 (21475)
Phase 3 (14492)
Pipeline (7636)
Policy (18)
Postmarket research (1571)
Preclinical (6559)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (586)
Real estate (3024)
Recruiting (6)
Regulatory (14942)
Reports (23)
Research institute (587)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2025)
Stomach cancer (3)
Supply chain (51)
Vaccines (334)
Venture capital (21)
Weight loss (74)
Women's health (85)
Date
Today (60)
Last 7 days (407)
Last 30 days (1325)
Last 365 days (19092)
2026 (13412)
2025 (19278)
2024 (23005)
2023 (26567)
2022 (34622)
2021 (37206)
2020 (33497)
2019 (23274)
2018 (17494)
2017 (18787)
2016 (17940)
2015 (24298)
2014 (21695)
2013 (18153)
2012 (20236)
2011 (20449)
2010 (20339)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (310)
Arkansas (11)
Asia (17972)
Australia (2110)
California (12292)
Canada (3218)
China (542)
Colorado (491)
Connecticut (424)
Delaware (211)
Europe (24772)
Florida (1846)
Georgia (397)
Hawaii (3)
Idaho (46)
Illinois (724)
India (52)
Indiana (321)
Iowa (16)
Japan (418)
Kansas (102)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1227)
Massachusetts (8067)
Michigan (312)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (120)
New Hampshire (60)
New Jersey (2681)
New Mexico (12)
New York (2881)
North Carolina (1315)
North Dakota (4)
Northern California (6178)
Ohio (290)
Oklahoma (14)
Oregon (18)
Pennsylvania (2294)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5113)
Tennessee (123)
Texas (1993)
United States (39859)
Utah (367)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (955)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
486,175 Results for "acell inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio
July 16, 2026
·
3 min read
Press Releases
Acelot Announces Appointment of Mark Forman, M.D., Ph.D., as Chief Development Officer and Chief Medical Officer
August 12, 2026
·
2 min read
Deals
Integra LifeSciences Completes the Acquisition of ACell, Inc.
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it completed the previously-disclosed acquisition of ACell, Inc.
January 20, 2021
·
2 min read
BioCapital
ACell Announces CE Mark Approval
ACell, Inc., a leading regenerative medicine company, announced today that it has received CE mark approval for its MicroMatrix®, Cytal® Wound Matrix, and Cytal® Burn Matrix devices
December 22, 2020
·
1 min read
Deals
Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc.Adds proprietary technology platform and complementary products to grow Integra’s regenerative portfolio
Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology company, today announced it has entered into a definitive agreement to acquire ACell, Inc.
December 16, 2020
·
5 min read
Press Releases
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
August 18, 2026
·
2 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Press Releases
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference
September 1, 2026
·
1 min read
1 of 48,618
Next
